We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App





New AI Technology Helps Hospitals Identify COVID-19 Patients Who Require ICU Treatment

By HospiMedica International staff writers
Posted on 07 Dec 2021
Print article
Illustration
Illustration

New technology could help doctors make the most of limited resources during the COVID-19 pandemic by identifying patients who require intensive care unit (ICU) treatment.

The system, developed by researchers at the University of Waterloo (Waterloo, ON, Canada) and DarwinAI (Waterloo, ON, Canada), an alumni-founded startup company, uses artificial intelligence (AI) to predict the necessity of ICU admission based on more than 200 clinical data points, including vital signs, blood test results and medical history. The new AI software was trained using data from almost 400 cases at Hospital Sirio-Libanes in Sao Paulo, Brazil, in which doctors had decided if COVID patients should be admitted for intensive care.

Based on lessons learned from that known data, the neural network developed by researchers can predict the need for ICU admission in new COVID cases with greater than 95% accuracy. It also identifies the key factors that drive its predictions to help give clinicians confidence in them. Rather than replacing doctors, the technology is meant to arm them with a new tool to make faster, more informed decisions and ensure the patients most in need of intensive care receive it. The researchers have made the technology freely available so engineers and scientists around the world can work to help improve it. They are now incorporating it into a larger clinical decision support system, developed in their ongoing COVID-Net open-source initiative, that also helps doctors detect COVID and determine its severity using AI analysis of medical images.

“That is a very important step in the clinical decision support process for triaging patients and developing treatment plans,” said Alexander Wong, a professor of systems design engineering and Canada Research Chair in AI and Medical Imaging at Waterloo. “The goal is to help clinicians make faster, more consistent decisions based on past patient cases and outcomes. It’s all about augmenting their expertise to optimize the use of medical resources and individualize patient care.”

Related Links:
University of Waterloo 
DarwinAI 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.